Drug Treatment Center - CytRx study reveals potential of molecular chaperones in design of - News-Medical.Net

CytRx study reveals potential of molecular chaperones in design of - News-Medical.Net
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification

Flu patients need not always seek medical attention - Press Republican
Published October 28, 2009 10:55 pm - CVPH Medical Center’s Emergency Department is overflowing with patients, many of whom have flu-like symptoms, but doctors suggest patients with flu stay home and rest if no underlying conditions exist. Flu

CytRx study reveals potential of molecular chaperones in design of - News-Medical.Net
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification

Flu patients need not always seek medical attention - Press Republican
Published October 28, 2009 10:55 pm - CVPH Medical Center’s Emergency Department is overflowing with patients, many of whom have flu-like symptoms, but doctors suggest patients with flu stay home and rest if no underlying conditions exist. Flu

Leave a Reply